CXCL12 and neoplasm: Reduced CXCL12 levels in an orthotopic tumor model using the murine ovarian cancer cell line ID8-T changed the composition of the immune cell population within tumors, reducing myeloid cells, plasmacytoid dendritic cells and Tregs, while increasing IFN-γ+/IL10+ tumor-infiltrating T lymphocytes [223].